{"gene":"GREM2","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":1998,"finding":"PRDC (GREM2) was identified as a novel secreted protein with a cysteine knot structure, belonging to the DAN/cerberus family of signaling molecules, expressed in commissural neurons of the developing spinal cord.","method":"Gene trap in ES cells, cDNA structural analysis, lacZ reporter expression in embryos","journal":"Development, growth & differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gene trap with germ-line transmission and reporter expression, single lab, structural characterization of cDNA","pmids":["9639362"],"is_preprint":false},{"year":2008,"finding":"PRDC (GREM2) inhibits osteoblastic differentiation by suppressing exogenous BMP activity and reducing phosphorylated Smad1/5/8 levels; forced PRDC expression inhibited bone marker genes and mineralization, while PRDC siRNA knockdown elevated alkaline phosphatase activity, increased pSmad1/5/8, and promoted mineralized matrix deposition.","method":"Adenoviral overexpression, siRNA knockdown, cell-based assays (ALP activity, mineralization), Western blot for pSmad1/5/8 in primary mouse osteoblasts","journal":"Experimental cell research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal gain- and loss-of-function with defined molecular readouts (pSmad1/5/8), two orthogonal methods (overexpression + siRNA), single lab","pmids":["19073177"],"is_preprint":false},{"year":2007,"finding":"PRDC (GREM2) expression is induced by Wnt/beta-catenin signaling in a Tcf/LEF-independent manner; the secreted PRDC induced by beta-catenin antagonizes BMP-4 signaling (but not Wnt signaling itself), establishing PRDC as a mediator linking Wnt activation to BMP-4 inhibition.","method":"Microarray, conditioned media BMP-4 reporter assay, Wnt pathway activation in L929 fibroblasts","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — functional reporter assay with conditioned media, single lab, single study","pmids":["17222801"],"is_preprint":false},{"year":2009,"finding":"PRDC (GREM2) modulates BMP signaling to regulate epibranchial placode neurogenesis in chick; gain-of-function PRDC caused loss of Bmp4 expression and inhibited placode neurogenesis, while loss-of-function induced ectopic Bmp4 and expanded placode neurogenesis.","method":"In ovo gain- and loss-of-function experiments in chick embryos, in situ hybridization for Bmp4 and placode markers","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal gain- and loss-of-function with defined molecular and cellular phenotypic readouts in chick model, single lab","pmids":["19836367"],"is_preprint":false},{"year":2012,"finding":"Recombinant mouse PRDC (GREM2) was shown to directly bind BMP2, BMP4, and BMP7 (but not activin A), and to inhibit BMP2 and BMP4 activity in a cell-based luciferase reporter assay, confirming its biochemical function as a BMP antagonist.","method":"Recombinant protein expression/purification from E. coli, direct binding assay, cell-based luciferase reporter assay, circular dichroism","journal":"Protein expression and purification","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with direct binding and functional cell-based assay, multiple orthogonal methods, single lab","pmids":["22381466"],"is_preprint":false},{"year":2012,"finding":"GREM2 regulates BMP signaling to control cardiac laterality and atrial cardiomyocyte differentiation during embryonic development; a Q76E variant with increased BMP inhibitory activity was identified in AF patients; GREM2 overactivity in zebrafish caused slower cardiac contraction rates and abnormal atrial contraction velocity; in mouse ES cells, GREM2 induced atrial-specific genes including connexin-40, sarcolipin and atrial natriuretic peptide.","method":"Sequencing of AF probands, zebrafish overexpression, live heart imaging, mouse ES cell differentiation, gene expression analysis","journal":"Disease models & mechanisms","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal in vivo and in vitro models, functional variant characterization, live imaging, replicated across species","pmids":["23223679"],"is_preprint":false},{"year":2014,"finding":"Grem2 knockout mice develop malformed mandibular and maxillary incisors, demonstrating that GREM2 is required for normal tooth morphogenesis in vivo.","method":"Grem2-/- mouse model, high-throughput phenotypic screen, histology, DEXA","journal":"Veterinary pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — clean KO mouse with defined dental phenotype, single lab, single method","pmids":["24686385"],"is_preprint":false},{"year":2016,"finding":"GREM2 antagonizes BMP2- and BMP4-induced gene expression in human fetal ovarian somatic cells in a gene-specific manner, fine-tuning BMP signal intensity to influence pre-granulosa cell differentiation around the time of primordial follicle formation.","method":"Primary human fetal ovarian somatic cell cultures treated with recombinant GREM1/GREM2 and BMP2/4, qRT-PCR for target gene expression","journal":"Molecular human reproduction","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — functional cell-based assay with recombinant protein in primary cells, single lab, single study","pmids":["27385727"],"is_preprint":false},{"year":2016,"finding":"Treatment of mouse embryonic stem cell-derived embryoid bodies with Grem2 (secreted BMP antagonist) drives differentiation toward atrial cardiomyocytes with atrial-like molecular, histological, and electrophysiological characteristics.","method":"Mouse ES cell differentiation protocol, Myh6-DSRed-Nuc reporter line, molecular/histological/electrophysiological analyses","journal":"Journal of visualized experiments : JoVE","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — defined differentiation protocol with multiple analytical readouts, single lab, single study","pmids":["27023256"],"is_preprint":false},{"year":2017,"finding":"Grem2 contains a heparin/heparan sulfate (HS)-binding motif composed of specific lysine residues; these residues are required for heparin/HS binding but not for BMP antagonism; the Grem2-BMP2 complex exhibits significantly higher heparin affinity than either protein alone, and this increase is partially independent of the Grem2 HS-binding epitope.","method":"Site-directed mutagenesis, heparin-binding measurements, cell surface-binding analysis, in vitro BMP antagonism assay","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis combined with quantitative binding assays and functional BMP antagonism assay, multiple orthogonal methods, single lab","pmids":["28104757"],"is_preprint":false},{"year":2019,"finding":"Grem2 promotes podocyte apoptosis in high-glucose conditions by increasing phosphorylation of Smad2/3 (pro-apoptotic TGF-β arm) and decreasing phosphorylation of Smad1/5/8 (pro-survival BMP arm); inhibiting Smad2/3 (SIS3) or activating Smad1/5/8 (BMP-7) attenuated Grem2-induced apoptosis.","method":"Podocyte transfection with Grem2 plasmid, siRNA knockdown, Western blot for pSmad2/3 and pSmad1/5/8, apoptosis assays, pharmacological rescue (SIS3, BMP-7)","journal":"Biochimie","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal overexpression and knockdown with molecular pathway readouts, pharmacological rescue, multiple orthogonal methods, single lab","pmids":["30831151"],"is_preprint":false},{"year":2019,"finding":"GREM2 maintains stem cell-like properties in gastric cancer stem cells through activation of the JNK signaling pathway; GREM2 silencing or JNK inhibition suppressed proliferation, migration, invasion, and promoted apoptosis in vitro, and inhibited tumorigenesis and lymph node metastasis in vivo.","method":"siRNA knockdown, JNK activator/inhibitor treatment, cell proliferation/migration/invasion/apoptosis assays, in vivo xenograft","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — loss-of-function with defined phenotypic readouts and pathway placement, single lab, single study","pmids":["31345097"],"is_preprint":false},{"year":2021,"finding":"GREM2 mutations associated with tooth agenesis reduce transcriptional activity of the GREM2 gene and decrease MSX1 expression; GREM2 mutant cells show increased cell migration and altered cell proliferation, demonstrating functional consequences of TA-associated variants.","method":"Transfection of SHED cells with mutant/reference GREM2 plasmids, luciferase transcriptional activity, Western blot, cell migration and proliferation assays, qRT-PCR for MSX1/PAX9/AXIN2","journal":"Orthodontics & craniofacial research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — functional variant characterization in relevant cell model with multiple readouts, single lab","pmids":["33369218"],"is_preprint":false},{"year":2022,"finding":"GREM2 inhibits the browning program of visceral preadipocytes partially by antagonizing BMP4/7-SMAD1/5/8 signaling through BMPR2; Grem2 overexpression reduced visceral fat browning capacity in mice, while Grem2 ablation enhanced browning and reduced visceral fat; preadipocyte-specific Bmpr2 knockout abolished Grem2's antagonistic effect on browning.","method":"Recombinant Grem2 protein treatment, Grem2 overexpression and knockout mouse models, Pdgfrα-specific Bmpr2 knockout mice, SMAD1/5/8 phosphorylation assays, circulating GREM2 ELISA","journal":"EBioMedicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal mouse models (overexpression, KO, receptor KO) with defined molecular mechanism, recombinant protein, single lab with strong evidence","pmids":["35349825"],"is_preprint":false},{"year":2022,"finding":"Decreased PRDC (GREM2) in pulmonary arterial hypertension lungs has a compensatory role; in vitro, PRDC reversed the effects of BMP2/4 on smooth muscle cell proliferation, migration, and apoptosis; in vivo PRDC supplementation deteriorated rat PAH, indicating that compensatory PRDC decrease slows disease progression.","method":"Human lung tissue analysis, monocrotaline rat PAH model, in vitro cell experiments (proliferation, migration, apoptosis assays), in vivo PRDC supplementation","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro mechanistic experiments with defined readouts plus in vivo supplementation model, single lab","pmids":["35414785"],"is_preprint":false},{"year":2024,"finding":"Partial Grem2 inactivation (Grem2+/- mice) increased trabecular BMD and trabecular thickness in female mice; Grem2 deletion stimulated osteoblast differentiation (elevated Alp, Bglap, Sp7 mRNA) after BMP-2 stimulation in calvarial and long bone osteoblasts, confirming GREM2 as a BMP antagonist suppressing osteoblastogenesis in vivo.","method":"Grem2+/- and Grem2-/- mouse models, micro-CT/DEXA bone analysis, primary osteoblast differentiation assays with BMP-2 stimulation, qRT-PCR","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean genetic mouse model with both in vivo skeletal phenotype and in vitro osteoblast mechanistic readouts, multiple methods, single lab","pmids":["38839844"],"is_preprint":false},{"year":2025,"finding":"GREM2 is a downstream transcriptional target of STAT3; dexamethasone inhibits STAT3 phosphorylation, thereby reducing GREM2 expression and downstream proinflammatory cytokines (TNF-α, IL-1β, CCL2) in thyroid cells.","method":"Dual-luciferase assay for STAT3-driven GREM2 transcription, siRNA interference of STAT3, in vitro LPS-stimulated thyroid cell model (Nthy-ori 3-1)","journal":"ACS omega","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — dual-luciferase and siRNA in single cell model, single lab, single study","pmids":["41322616"],"is_preprint":false},{"year":2025,"finding":"Grem2 knockdown in renal tubular epithelial cells prevented fibrosis and senescence induced by high glucose and cholesterol, indicating that elevated Grem2 mediates epithelial-mesenchymal transition and tubular injury in diabetic kidney disease.","method":"siRNA knockdown of Grem2 in RTECs under high glucose/cholesterol, Western blot for EMT markers (desmin, α-SMA, fibronectin), db/db mouse model with SMUP-Cell treatment","journal":"International journal of stem cells","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — in vitro knockdown with defined functional readouts, supported by in vivo transcriptome data, single lab","pmids":["39757007"],"is_preprint":false}],"current_model":"GREM2 (PRDC/Gremlin-2) is a secreted BMP antagonist of the DAN family that directly binds BMP2, BMP4, and BMP7 through a cysteine knot structure to inhibit BMP receptor signaling; it modulates SMAD1/5/8 (BMP arm) and SMAD2/3 (TGF-β arm) phosphorylation to regulate osteoblast differentiation, atrial cardiomyocyte specification, tooth morphogenesis, visceral fat browning, placode neurogenesis, and podocyte survival, and its expression is transcriptionally regulated by Wnt/β-catenin and STAT3 signaling, and post-transcriptionally by multiple miRNAs."},"narrative":{"mechanistic_narrative":"GREM2 (PRDC) is a secreted DAN-family BMP antagonist with a cysteine-knot fold that directly binds BMP2, BMP4, and BMP7 — but not activin A — to block BMP receptor signaling and lower SMAD1/5/8 phosphorylation [PMID:9639362, PMID:22381466]. Through this antagonism it tunes BMP signal intensity during multiple developmental and homeostatic programs: it suppresses osteoblast differentiation and mineralization, with reciprocal loss-of-function elevating pSMAD1/5/8 and bone marker expression and Grem2-deficient mice showing increased trabecular bone mass [PMID:19073177, PMID:38839844]; it shapes epibranchial placode neurogenesis via control of Bmp4 [PMID:19836367]; and it drives atrial cardiomyocyte specification, where a gain-of-function Q76E variant with enhanced BMP-inhibitory activity is linked to atrial fibrillation [PMID:23223679, PMID:27023256]. GREM2 also inhibits visceral fat browning by antagonizing BMP4/7–SMAD1/5/8 signaling specifically through the receptor BMPR2 [PMID:35349825], and it is required for normal tooth morphogenesis, with tooth-agenesis-associated variants reducing GREM2 transcriptional activity and downstream MSX1 expression [PMID:24686385, PMID:33369218]. Beyond canonical BMP inhibition, GREM2 can shift SMAD balance pathologically, increasing pro-apoptotic SMAD2/3 while lowering pro-survival SMAD1/5/8 to promote podocyte apoptosis, and elevated GREM2 mediates EMT and tubular injury in diabetic kidney disease [PMID:30831151, PMID:39757007]. Its expression is induced by Wnt/β-catenin signaling in a Tcf/LEF-independent manner and by STAT3, positioning GREM2 as a regulated node coupling upstream pathways to BMP output [PMID:17222801, PMID:41322616]. GREM2 additionally possesses a lysine-rich heparin/heparan-sulfate-binding motif that is dispensable for BMP antagonism but enhances heparin affinity of the GREM2–BMP2 complex [PMID:28104757].","teleology":[{"year":1998,"claim":"Establishing GREM2's molecular identity: it was unknown what PRDC was, and structural cloning defined it as a secreted cysteine-knot protein of the DAN/cerberus signaling family expressed in developing neurons.","evidence":"Gene trap in ES cells, cDNA structural analysis, lacZ reporter in embryos","pmids":["9639362"],"confidence":"Medium","gaps":["No biochemical ligand or receptor identified at this stage","Functional role inferred only from family membership and expression pattern"]},{"year":2007,"claim":"Addressing how GREM2 is regulated and what it connects to: Wnt/β-catenin was shown to induce GREM2 in a Tcf/LEF-independent way, and the induced protein antagonized BMP-4 but not Wnt, placing GREM2 as a Wnt-to-BMP relay.","evidence":"Microarray and conditioned-media BMP-4 reporter assay in L929 fibroblasts","pmids":["17222801"],"confidence":"Medium","gaps":["Mechanism of Tcf/LEF-independent induction unresolved","Single cell-line context, no in vivo confirmation"]},{"year":2008,"claim":"Demonstrating cellular function: GREM2 was shown to suppress osteoblast differentiation, with reciprocal gain/loss-of-function tying its effect directly to pSMAD1/5/8 levels.","evidence":"Adenoviral overexpression and siRNA in primary mouse osteoblasts, ALP/mineralization assays, pSMAD1/5/8 Western blot","pmids":["19073177"],"confidence":"High","gaps":["Direct ligand binding not yet demonstrated in this study","In vivo skeletal relevance not addressed"]},{"year":2009,"claim":"Testing developmental function in vivo: reciprocal gain/loss-of-function in chick established that GREM2 controls epibranchial placode neurogenesis through regulation of Bmp4.","evidence":"In ovo gain- and loss-of-function in chick embryos with in situ hybridization","pmids":["19836367"],"confidence":"High","gaps":["Mechanism of Bmp4 feedback regulation not defined","No mammalian validation"]},{"year":2012,"claim":"Defining the biochemical mechanism and cardiac role: recombinant GREM2 was shown to bind BMP2/4/7 directly and inhibit BMP activity, and an AF-associated Q76E gain-of-function variant linked GREM2-controlled BMP signaling to atrial cardiomyocyte differentiation and cardiac laterality.","evidence":"Recombinant protein binding and luciferase assays, circular dichroism; AF proband sequencing, zebrafish overexpression with live imaging, mouse ES cell differentiation","pmids":["22381466","23223679"],"confidence":"High","gaps":["Receptor-level mechanism not resolved","Causal contribution of Q76E to human AF not established at population scale"]},{"year":2014,"claim":"Confirming a required developmental role: Grem2 knockout mice display malformed incisors, showing GREM2 is necessary for normal tooth morphogenesis.","evidence":"Grem2-/- mouse model with histology and DEXA phenotyping","pmids":["24686385"],"confidence":"Medium","gaps":["Molecular pathway driving dental phenotype not dissected","Single-method phenotypic description"]},{"year":2016,"claim":"Extending BMP fine-tuning to reproduction and cardiac differentiation: GREM2 was shown to antagonize BMP2/4 gene-specifically in human fetal ovarian somatic cells and to drive atrial-like cardiomyocyte differentiation from ES-derived embryoid bodies.","evidence":"Recombinant GREM2 on primary human fetal ovarian cells with qRT-PCR; mouse ES embryoid-body differentiation with molecular/histological/electrophysiological readouts","pmids":["27385727","27023256"],"confidence":"Medium","gaps":["Gene-specificity mechanism of BMP modulation unexplained","In vivo ovarian role not tested"]},{"year":2017,"claim":"Resolving a non-BMP biochemical property: GREM2 carries a lysine-rich heparin/HS-binding motif dispensable for BMP antagonism, and the GREM2–BMP2 complex binds heparin more avidly than either partner alone.","evidence":"Site-directed mutagenesis, heparin-binding and cell-surface binding assays, BMP antagonism assay","pmids":["28104757"],"confidence":"High","gaps":["Physiological role of heparin/HS binding in vivo unknown","How HS binding shapes extracellular GREM2 distribution unresolved"]},{"year":2019,"claim":"Uncovering a pathological SMAD-balance mechanism and a cancer role: GREM2 was shown to promote podocyte apoptosis by shifting SMAD2/3 up and SMAD1/5/8 down, and separately to maintain gastric cancer stem-cell properties through JNK signaling.","evidence":"Podocyte overexpression/knockdown with pSMAD Western blots and pharmacological rescue (SIS3, BMP-7); gastric CSC siRNA knockdown with JNK modulation and xenografts","pmids":["30831151","31345097"],"confidence":"High","gaps":["How GREM2 differentially biases the two SMAD arms is unknown","Link between BMP antagonism and JNK activation not mechanistically connected"]},{"year":2021,"claim":"Linking human variants to mechanism: tooth-agenesis-associated GREM2 mutations reduce GREM2 transcriptional activity and lower MSX1 expression while altering cell migration/proliferation.","evidence":"Mutant/reference GREM2 transfection in SHED cells, luciferase, Western blot, migration/proliferation assays, qRT-PCR of MSX1/PAX9/AXIN2","pmids":["33369218"],"confidence":"Medium","gaps":["Causal chain from reduced GREM2 to dental agenesis not established in vivo","Single cell-model functional inference"]},{"year":2022,"claim":"Defining receptor-level mechanism in metabolism and a compensatory disease role: GREM2 inhibits visceral fat browning by antagonizing BMP4/7–SMAD1/5/8 specifically via BMPR2, and decreased PRDC in pulmonary arterial hypertension acts compensatorily on smooth-muscle behavior.","evidence":"Grem2 overexpression/KO and Pdgfrα-specific Bmpr2 KO mice, recombinant Grem2, SMAD1/5/8 assays, ELISA; monocrotaline rat PAH model with PRDC supplementation and in vitro SMC assays","pmids":["35349825","35414785"],"confidence":"High","gaps":["Whether BMPR2 dependence generalizes to other GREM2 contexts unknown","Source and regulation of circulating GREM2 not defined"]},{"year":2024,"claim":"Confirming the skeletal phenotype genetically: partial and full Grem2 inactivation increased trabecular bone mass and enhanced BMP-2-stimulated osteoblast differentiation, validating GREM2 as an in vivo suppressor of osteoblastogenesis.","evidence":"Grem2+/- and Grem2-/- mice, micro-CT/DEXA, primary osteoblast differentiation with BMP-2 and qRT-PCR","pmids":["38839844"],"confidence":"High","gaps":["Sex-specificity of the BMD phenotype not explained","Cell-type origin of the effect not isolated"]},{"year":2025,"claim":"Identifying an upstream transcriptional regulator and an inflammatory/fibrotic context: GREM2 is a STAT3 transcriptional target whose suppression reduces proinflammatory cytokines, and GREM2 knockdown prevents high-glucose/cholesterol-induced renal tubular fibrosis and senescence.","evidence":"STAT3 dual-luciferase and siRNA in LPS-stimulated thyroid cells; Grem2 siRNA in renal tubular epithelial cells with EMT markers and db/db mouse data","pmids":["41322616","39757007"],"confidence":"Medium","gaps":["Whether STAT3-driven GREM2 acts through BMP antagonism in inflammation is unclear","Direct vs indirect role of GREM2 in EMT not separated"]},{"year":null,"claim":"How GREM2 mechanistically biases between the BMP (SMAD1/5/8) and TGF-β (SMAD2/3) arms, and how receptor selectivity (e.g., BMPR2 dependence) and heparan-sulfate binding shape its tissue-specific outputs, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of GREM2–BMP–receptor assembly","Mechanism of SMAD-arm switching unknown","Physiological function of HS binding undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,4,13,15]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,2,4]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,4,10,13]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,5,6]}],"complexes":[],"partners":["BMP2","BMP4","BMP7","BMPR2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9H772","full_name":"Gremlin-2","aliases":["Cysteine knot superfamily 1, BMP antagonist 2","DAN domain family member 3","Protein related to DAN and cerberus"],"length_aa":168,"mass_kda":19.3,"function":"Cytokine that inhibits the activity of BMP2 and BMP4 in a dose-dependent manner, and thereby modulates signaling by BMP family members. Contributes to the regulation of embryonic morphogenesis via BMP family members. Antagonizes BMP4-induced suppression of progesterone production in granulosa cells","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/Q9H772/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GREM2","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GREM2","total_profiled":1310},"omim":[{"mim_id":"617275","title":"TOOTH AGENESIS, SELECTIVE, 9; STHAG9","url":"https://www.omim.org/entry/617275"},{"mim_id":"608832","title":"GREMLIN 2, DAN FAMILY BMP ANTAGONIST; GREM2","url":"https://www.omim.org/entry/608832"},{"mim_id":"106600","title":"TOOTH AGENESIS, SELECTIVE, 1; STHAG1","url":"https://www.omim.org/entry/106600"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"gallbladder","ntpm":29.4},{"tissue":"liver","ntpm":24.6}],"url":"https://www.proteinatlas.org/search/GREM2"},"hgnc":{"alias_symbol":["Prdc","FLJ21195","CKTSF1B2","DAND3"],"prev_symbol":[]},"alphafold":{"accession":"Q9H772","domains":[{"cath_id":"2.10.90.10","chopping":"69-162","consensus_level":"medium","plddt":92.7907,"start":69,"end":162}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H772","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H772-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H772-F1-predicted_aligned_error_v6.png","plddt_mean":79.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GREM2","jax_strain_url":"https://www.jax.org/strain/search?query=GREM2"},"sequence":{"accession":"Q9H772","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9H772.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9H772/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H772"}},"corpus_meta":[{"pmid":"33144675","id":"PMC_33144675","title":"Cancer-associated fibroblast-secreted exosomal miR-423-5p promotes chemotherapy resistance in prostate cancer by targeting GREM2 through the TGF-β signaling pathway.","date":"2020","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33144675","citation_count":104,"is_preprint":false},{"pmid":"37422021","id":"PMC_37422021","title":"SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis.","date":"2023","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/37422021","citation_count":99,"is_preprint":false},{"pmid":"9639362","id":"PMC_9639362","title":"Sequence and expression of a novel mouse gene PRDC (protein related to DAN and cerberus) identified by a gene trap approach.","date":"1998","source":"Development, growth & differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/9639362","citation_count":49,"is_preprint":false},{"pmid":"15254711","id":"PMC_15254711","title":"Identification and characterization of human CKTSF1B2 and CKTSF1B3 genes in silico.","date":"2004","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/15254711","citation_count":48,"is_preprint":false},{"pmid":"19073177","id":"PMC_19073177","title":"Protein related to DAN and cerberus (PRDC) inhibits osteoblastic differentiation and its suppression promotes osteogenesis in vitro.","date":"2008","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/19073177","citation_count":47,"is_preprint":false},{"pmid":"23223679","id":"PMC_23223679","title":"Functional modeling in zebrafish demonstrates that the atrial-fibrillation-associated gene GREM2 regulates cardiac laterality, cardiomyocyte differentiation and atrial rhythm.","date":"2012","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/23223679","citation_count":44,"is_preprint":false},{"pmid":"27385727","id":"PMC_27385727","title":"BMP signalling in human fetal ovary somatic cells is modulated in a gene-specific fashion by GREM1 and GREM2.","date":"2016","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/27385727","citation_count":28,"is_preprint":false},{"pmid":"16921498","id":"PMC_16921498","title":"Expression of the protein related to Dan and Cerberus gene--prdc--During eye, pharyngeal arch, somite, and swim bladder development in zebrafish.","date":"2006","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/16921498","citation_count":27,"is_preprint":false},{"pmid":"17222801","id":"PMC_17222801","title":"Wnt/beta-catenin signaling regulates expression of PRDC, an antagonist of the BMP-4 signaling pathway.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17222801","citation_count":27,"is_preprint":false},{"pmid":"34049478","id":"PMC_34049478","title":"LncRNA DNM3OS regulates GREM2 via miR-127-5p to suppress early chondrogenic differentiation of rat mesenchymal stem cells under hypoxic conditions.","date":"2021","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/34049478","citation_count":26,"is_preprint":false},{"pmid":"19836367","id":"PMC_19836367","title":"PRDC regulates placode neurogenesis in chick by modulating BMP signalling.","date":"2009","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19836367","citation_count":25,"is_preprint":false},{"pmid":"24686385","id":"PMC_24686385","title":"Malformation of incisor teeth in Grem2⁻/⁻ mice.","date":"2014","source":"Veterinary pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24686385","citation_count":24,"is_preprint":false},{"pmid":"35619575","id":"PMC_35619575","title":"MiR-103a-3p Contributes to the Progression of Colorectal Cancer by Regulating GREM2 Expression.","date":"2022","source":"Yonsei medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/35619575","citation_count":17,"is_preprint":false},{"pmid":"30831151","id":"PMC_30831151","title":"Grem2 mediates podocyte apoptosis in high glucose milieu.","date":"2019","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/30831151","citation_count":17,"is_preprint":false},{"pmid":"34973370","id":"PMC_34973370","title":"miR-122-5p targets GREM2 to protect against glucocorticoid-induced endothelial damage through the BMP signaling pathway.","date":"2021","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/34973370","citation_count":15,"is_preprint":false},{"pmid":"23902946","id":"PMC_23902946","title":"Genetic variants in GREM2 are associated with bone mineral density in a southern Chinese population.","date":"2013","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/23902946","citation_count":13,"is_preprint":false},{"pmid":"30246922","id":"PMC_30246922","title":"Further evidence for the role of WNT10A, WNT10B and GREM2 as candidate genes for isolated tooth agenesis.","date":"2018","source":"Orthodontics & craniofacial research","url":"https://pubmed.ncbi.nlm.nih.gov/30246922","citation_count":13,"is_preprint":false},{"pmid":"31345097","id":"PMC_31345097","title":"GREM2 maintains stem cell-like phenotypes in gastric cancer cells by regulating the JNK signaling pathway.","date":"2019","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/31345097","citation_count":12,"is_preprint":false},{"pmid":"28992378","id":"PMC_28992378","title":"GREM2 nucleotide variants and the risk of tooth agenesis.","date":"2017","source":"Oral diseases","url":"https://pubmed.ncbi.nlm.nih.gov/28992378","citation_count":12,"is_preprint":false},{"pmid":"28104757","id":"PMC_28104757","title":"Analysis and identification of the Grem2 heparin/heparan sulfate-binding motif.","date":"2017","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/28104757","citation_count":11,"is_preprint":false},{"pmid":"34349344","id":"PMC_34349344","title":"Inhibiting roles of FOXA2 in liver cancer cell migration and invasion by transcriptionally suppressing microRNA-103a-3p and activating the GREM2/LATS2/YAP axis.","date":"2021","source":"Cytotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/34349344","citation_count":11,"is_preprint":false},{"pmid":"22381466","id":"PMC_22381466","title":"Expression and purification of recombinant protein related to DAN and cerberus (PRDC).","date":"2012","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/22381466","citation_count":9,"is_preprint":false},{"pmid":"35349825","id":"PMC_35349825","title":"GREM2 is associated with human central obesity and inhibits visceral preadipocyte browning.","date":"2022","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/35349825","citation_count":9,"is_preprint":false},{"pmid":"33369218","id":"PMC_33369218","title":"Functional characterization of ATF1, GREM2 AND WNT10B variants associated with tooth agenesis.","date":"2021","source":"Orthodontics & craniofacial research","url":"https://pubmed.ncbi.nlm.nih.gov/33369218","citation_count":6,"is_preprint":false},{"pmid":"35414785","id":"PMC_35414785","title":"Compensatory roles of Protein Related to DAN and Cerberus (PRDC) decrease in pulmonary arterial hypertension.","date":"2022","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35414785","citation_count":5,"is_preprint":false},{"pmid":"27023256","id":"PMC_27023256","title":"Differentiation of Atrial Cardiomyocytes from Pluripotent Stem Cells Using the BMP Antagonist Grem2.","date":"2016","source":"Journal of visualized experiments : JoVE","url":"https://pubmed.ncbi.nlm.nih.gov/27023256","citation_count":4,"is_preprint":false},{"pmid":"38941907","id":"PMC_38941907","title":"6-Shogaol alleviates high-fat diet induced hepatic steatosis through miR-3066-5p/Grem2 pathway.","date":"2024","source":"Food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38941907","citation_count":3,"is_preprint":false},{"pmid":"40500779","id":"PMC_40500779","title":"Overexpression of miR-671-3p alleviates postmenopausal osteoporosis by targeting GREM2 to activate BMP2/SMAD signaling pathway.","date":"2025","source":"Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/40500779","citation_count":2,"is_preprint":false},{"pmid":"38839844","id":"PMC_38839844","title":"GREM2 inactivation increases trabecular bone mass in mice.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/38839844","citation_count":2,"is_preprint":false},{"pmid":"39757007","id":"PMC_39757007","title":"Mesenchymal Stem Cells Mediated Suppression of GREM2 Inhibits Renal Epithelial-Mesenchymal Transition and Attenuates the Progression of Diabetic Kidney Disease.","date":"2025","source":"International journal of stem cells","url":"https://pubmed.ncbi.nlm.nih.gov/39757007","citation_count":2,"is_preprint":false},{"pmid":"41322616","id":"PMC_41322616","title":"Integrative Transcriptome and Machine Learning Analysis Uncovers Critical STAT3/GREM2 Signaling Mechanisms in Dexamethasone Treatment of Hashimoto's Thyroiditis.","date":"2025","source":"ACS omega","url":"https://pubmed.ncbi.nlm.nih.gov/41322616","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.06.26.600819","title":"Biofilm formation in  <i>Streptococcus suis</i>  :  <i>In vitro</i>  impact of serovar and assessment of coinfections with other porcine respiratory disease complex bacterial pathogens","date":"2024-06-27","source":"bioRxiv","url":"https://doi.org/10.1101/2024.06.26.600819","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.04.07.25325355","title":"Hierarchical representation learning of preeclampsia interactome connecting endometrial maturation, placentation, chorioamnionitis, and HELLP syndrome","date":"2025-04-07","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.07.25325355","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":19859,"output_tokens":4406,"usd":0.062834,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":12378,"output_tokens":4551,"usd":0.087832,"stage2_stop_reason":"end_turn"},"total_usd":0.150666,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"PRDC (GREM2) was identified as a novel secreted protein with a cysteine knot structure, belonging to the DAN/cerberus family of signaling molecules, expressed in commissural neurons of the developing spinal cord.\",\n      \"method\": \"Gene trap in ES cells, cDNA structural analysis, lacZ reporter expression in embryos\",\n      \"journal\": \"Development, growth & differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gene trap with germ-line transmission and reporter expression, single lab, structural characterization of cDNA\",\n      \"pmids\": [\"9639362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PRDC (GREM2) inhibits osteoblastic differentiation by suppressing exogenous BMP activity and reducing phosphorylated Smad1/5/8 levels; forced PRDC expression inhibited bone marker genes and mineralization, while PRDC siRNA knockdown elevated alkaline phosphatase activity, increased pSmad1/5/8, and promoted mineralized matrix deposition.\",\n      \"method\": \"Adenoviral overexpression, siRNA knockdown, cell-based assays (ALP activity, mineralization), Western blot for pSmad1/5/8 in primary mouse osteoblasts\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal gain- and loss-of-function with defined molecular readouts (pSmad1/5/8), two orthogonal methods (overexpression + siRNA), single lab\",\n      \"pmids\": [\"19073177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PRDC (GREM2) expression is induced by Wnt/beta-catenin signaling in a Tcf/LEF-independent manner; the secreted PRDC induced by beta-catenin antagonizes BMP-4 signaling (but not Wnt signaling itself), establishing PRDC as a mediator linking Wnt activation to BMP-4 inhibition.\",\n      \"method\": \"Microarray, conditioned media BMP-4 reporter assay, Wnt pathway activation in L929 fibroblasts\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — functional reporter assay with conditioned media, single lab, single study\",\n      \"pmids\": [\"17222801\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PRDC (GREM2) modulates BMP signaling to regulate epibranchial placode neurogenesis in chick; gain-of-function PRDC caused loss of Bmp4 expression and inhibited placode neurogenesis, while loss-of-function induced ectopic Bmp4 and expanded placode neurogenesis.\",\n      \"method\": \"In ovo gain- and loss-of-function experiments in chick embryos, in situ hybridization for Bmp4 and placode markers\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal gain- and loss-of-function with defined molecular and cellular phenotypic readouts in chick model, single lab\",\n      \"pmids\": [\"19836367\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Recombinant mouse PRDC (GREM2) was shown to directly bind BMP2, BMP4, and BMP7 (but not activin A), and to inhibit BMP2 and BMP4 activity in a cell-based luciferase reporter assay, confirming its biochemical function as a BMP antagonist.\",\n      \"method\": \"Recombinant protein expression/purification from E. coli, direct binding assay, cell-based luciferase reporter assay, circular dichroism\",\n      \"journal\": \"Protein expression and purification\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with direct binding and functional cell-based assay, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"22381466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GREM2 regulates BMP signaling to control cardiac laterality and atrial cardiomyocyte differentiation during embryonic development; a Q76E variant with increased BMP inhibitory activity was identified in AF patients; GREM2 overactivity in zebrafish caused slower cardiac contraction rates and abnormal atrial contraction velocity; in mouse ES cells, GREM2 induced atrial-specific genes including connexin-40, sarcolipin and atrial natriuretic peptide.\",\n      \"method\": \"Sequencing of AF probands, zebrafish overexpression, live heart imaging, mouse ES cell differentiation, gene expression analysis\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal in vivo and in vitro models, functional variant characterization, live imaging, replicated across species\",\n      \"pmids\": [\"23223679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Grem2 knockout mice develop malformed mandibular and maxillary incisors, demonstrating that GREM2 is required for normal tooth morphogenesis in vivo.\",\n      \"method\": \"Grem2-/- mouse model, high-throughput phenotypic screen, histology, DEXA\",\n      \"journal\": \"Veterinary pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — clean KO mouse with defined dental phenotype, single lab, single method\",\n      \"pmids\": [\"24686385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GREM2 antagonizes BMP2- and BMP4-induced gene expression in human fetal ovarian somatic cells in a gene-specific manner, fine-tuning BMP signal intensity to influence pre-granulosa cell differentiation around the time of primordial follicle formation.\",\n      \"method\": \"Primary human fetal ovarian somatic cell cultures treated with recombinant GREM1/GREM2 and BMP2/4, qRT-PCR for target gene expression\",\n      \"journal\": \"Molecular human reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — functional cell-based assay with recombinant protein in primary cells, single lab, single study\",\n      \"pmids\": [\"27385727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Treatment of mouse embryonic stem cell-derived embryoid bodies with Grem2 (secreted BMP antagonist) drives differentiation toward atrial cardiomyocytes with atrial-like molecular, histological, and electrophysiological characteristics.\",\n      \"method\": \"Mouse ES cell differentiation protocol, Myh6-DSRed-Nuc reporter line, molecular/histological/electrophysiological analyses\",\n      \"journal\": \"Journal of visualized experiments : JoVE\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — defined differentiation protocol with multiple analytical readouts, single lab, single study\",\n      \"pmids\": [\"27023256\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Grem2 contains a heparin/heparan sulfate (HS)-binding motif composed of specific lysine residues; these residues are required for heparin/HS binding but not for BMP antagonism; the Grem2-BMP2 complex exhibits significantly higher heparin affinity than either protein alone, and this increase is partially independent of the Grem2 HS-binding epitope.\",\n      \"method\": \"Site-directed mutagenesis, heparin-binding measurements, cell surface-binding analysis, in vitro BMP antagonism assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis combined with quantitative binding assays and functional BMP antagonism assay, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"28104757\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Grem2 promotes podocyte apoptosis in high-glucose conditions by increasing phosphorylation of Smad2/3 (pro-apoptotic TGF-β arm) and decreasing phosphorylation of Smad1/5/8 (pro-survival BMP arm); inhibiting Smad2/3 (SIS3) or activating Smad1/5/8 (BMP-7) attenuated Grem2-induced apoptosis.\",\n      \"method\": \"Podocyte transfection with Grem2 plasmid, siRNA knockdown, Western blot for pSmad2/3 and pSmad1/5/8, apoptosis assays, pharmacological rescue (SIS3, BMP-7)\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal overexpression and knockdown with molecular pathway readouts, pharmacological rescue, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"30831151\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GREM2 maintains stem cell-like properties in gastric cancer stem cells through activation of the JNK signaling pathway; GREM2 silencing or JNK inhibition suppressed proliferation, migration, invasion, and promoted apoptosis in vitro, and inhibited tumorigenesis and lymph node metastasis in vivo.\",\n      \"method\": \"siRNA knockdown, JNK activator/inhibitor treatment, cell proliferation/migration/invasion/apoptosis assays, in vivo xenograft\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — loss-of-function with defined phenotypic readouts and pathway placement, single lab, single study\",\n      \"pmids\": [\"31345097\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GREM2 mutations associated with tooth agenesis reduce transcriptional activity of the GREM2 gene and decrease MSX1 expression; GREM2 mutant cells show increased cell migration and altered cell proliferation, demonstrating functional consequences of TA-associated variants.\",\n      \"method\": \"Transfection of SHED cells with mutant/reference GREM2 plasmids, luciferase transcriptional activity, Western blot, cell migration and proliferation assays, qRT-PCR for MSX1/PAX9/AXIN2\",\n      \"journal\": \"Orthodontics & craniofacial research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — functional variant characterization in relevant cell model with multiple readouts, single lab\",\n      \"pmids\": [\"33369218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GREM2 inhibits the browning program of visceral preadipocytes partially by antagonizing BMP4/7-SMAD1/5/8 signaling through BMPR2; Grem2 overexpression reduced visceral fat browning capacity in mice, while Grem2 ablation enhanced browning and reduced visceral fat; preadipocyte-specific Bmpr2 knockout abolished Grem2's antagonistic effect on browning.\",\n      \"method\": \"Recombinant Grem2 protein treatment, Grem2 overexpression and knockout mouse models, Pdgfrα-specific Bmpr2 knockout mice, SMAD1/5/8 phosphorylation assays, circulating GREM2 ELISA\",\n      \"journal\": \"EBioMedicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal mouse models (overexpression, KO, receptor KO) with defined molecular mechanism, recombinant protein, single lab with strong evidence\",\n      \"pmids\": [\"35349825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Decreased PRDC (GREM2) in pulmonary arterial hypertension lungs has a compensatory role; in vitro, PRDC reversed the effects of BMP2/4 on smooth muscle cell proliferation, migration, and apoptosis; in vivo PRDC supplementation deteriorated rat PAH, indicating that compensatory PRDC decrease slows disease progression.\",\n      \"method\": \"Human lung tissue analysis, monocrotaline rat PAH model, in vitro cell experiments (proliferation, migration, apoptosis assays), in vivo PRDC supplementation\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro mechanistic experiments with defined readouts plus in vivo supplementation model, single lab\",\n      \"pmids\": [\"35414785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Partial Grem2 inactivation (Grem2+/- mice) increased trabecular BMD and trabecular thickness in female mice; Grem2 deletion stimulated osteoblast differentiation (elevated Alp, Bglap, Sp7 mRNA) after BMP-2 stimulation in calvarial and long bone osteoblasts, confirming GREM2 as a BMP antagonist suppressing osteoblastogenesis in vivo.\",\n      \"method\": \"Grem2+/- and Grem2-/- mouse models, micro-CT/DEXA bone analysis, primary osteoblast differentiation assays with BMP-2 stimulation, qRT-PCR\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic mouse model with both in vivo skeletal phenotype and in vitro osteoblast mechanistic readouts, multiple methods, single lab\",\n      \"pmids\": [\"38839844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GREM2 is a downstream transcriptional target of STAT3; dexamethasone inhibits STAT3 phosphorylation, thereby reducing GREM2 expression and downstream proinflammatory cytokines (TNF-α, IL-1β, CCL2) in thyroid cells.\",\n      \"method\": \"Dual-luciferase assay for STAT3-driven GREM2 transcription, siRNA interference of STAT3, in vitro LPS-stimulated thyroid cell model (Nthy-ori 3-1)\",\n      \"journal\": \"ACS omega\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — dual-luciferase and siRNA in single cell model, single lab, single study\",\n      \"pmids\": [\"41322616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Grem2 knockdown in renal tubular epithelial cells prevented fibrosis and senescence induced by high glucose and cholesterol, indicating that elevated Grem2 mediates epithelial-mesenchymal transition and tubular injury in diabetic kidney disease.\",\n      \"method\": \"siRNA knockdown of Grem2 in RTECs under high glucose/cholesterol, Western blot for EMT markers (desmin, α-SMA, fibronectin), db/db mouse model with SMUP-Cell treatment\",\n      \"journal\": \"International journal of stem cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — in vitro knockdown with defined functional readouts, supported by in vivo transcriptome data, single lab\",\n      \"pmids\": [\"39757007\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GREM2 (PRDC/Gremlin-2) is a secreted BMP antagonist of the DAN family that directly binds BMP2, BMP4, and BMP7 through a cysteine knot structure to inhibit BMP receptor signaling; it modulates SMAD1/5/8 (BMP arm) and SMAD2/3 (TGF-β arm) phosphorylation to regulate osteoblast differentiation, atrial cardiomyocyte specification, tooth morphogenesis, visceral fat browning, placode neurogenesis, and podocyte survival, and its expression is transcriptionally regulated by Wnt/β-catenin and STAT3 signaling, and post-transcriptionally by multiple miRNAs.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GREM2 (PRDC) is a secreted DAN-family BMP antagonist with a cysteine-knot fold that directly binds BMP2, BMP4, and BMP7 — but not activin A — to block BMP receptor signaling and lower SMAD1/5/8 phosphorylation [#0, #4]. Through this antagonism it tunes BMP signal intensity during multiple developmental and homeostatic programs: it suppresses osteoblast differentiation and mineralization, with reciprocal loss-of-function elevating pSMAD1/5/8 and bone marker expression and Grem2-deficient mice showing increased trabecular bone mass [#1, #15]; it shapes epibranchial placode neurogenesis via control of Bmp4 [#3]; and it drives atrial cardiomyocyte specification, where a gain-of-function Q76E variant with enhanced BMP-inhibitory activity is linked to atrial fibrillation [#5, #8]. GREM2 also inhibits visceral fat browning by antagonizing BMP4/7–SMAD1/5/8 signaling specifically through the receptor BMPR2 [#13], and it is required for normal tooth morphogenesis, with tooth-agenesis-associated variants reducing GREM2 transcriptional activity and downstream MSX1 expression [#6, #12]. Beyond canonical BMP inhibition, GREM2 can shift SMAD balance pathologically, increasing pro-apoptotic SMAD2/3 while lowering pro-survival SMAD1/5/8 to promote podocyte apoptosis, and elevated GREM2 mediates EMT and tubular injury in diabetic kidney disease [#10, #17]. Its expression is induced by Wnt/β-catenin signaling in a Tcf/LEF-independent manner and by STAT3, positioning GREM2 as a regulated node coupling upstream pathways to BMP output [#2, #16]. GREM2 additionally possesses a lysine-rich heparin/heparan-sulfate-binding motif that is dispensable for BMP antagonism but enhances heparin affinity of the GREM2–BMP2 complex [#9].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing GREM2's molecular identity: it was unknown what PRDC was, and structural cloning defined it as a secreted cysteine-knot protein of the DAN/cerberus signaling family expressed in developing neurons.\",\n      \"evidence\": \"Gene trap in ES cells, cDNA structural analysis, lacZ reporter in embryos\",\n      \"pmids\": [\"9639362\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No biochemical ligand or receptor identified at this stage\", \"Functional role inferred only from family membership and expression pattern\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Addressing how GREM2 is regulated and what it connects to: Wnt/β-catenin was shown to induce GREM2 in a Tcf/LEF-independent way, and the induced protein antagonized BMP-4 but not Wnt, placing GREM2 as a Wnt-to-BMP relay.\",\n      \"evidence\": \"Microarray and conditioned-media BMP-4 reporter assay in L929 fibroblasts\",\n      \"pmids\": [\"17222801\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of Tcf/LEF-independent induction unresolved\", \"Single cell-line context, no in vivo confirmation\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrating cellular function: GREM2 was shown to suppress osteoblast differentiation, with reciprocal gain/loss-of-function tying its effect directly to pSMAD1/5/8 levels.\",\n      \"evidence\": \"Adenoviral overexpression and siRNA in primary mouse osteoblasts, ALP/mineralization assays, pSMAD1/5/8 Western blot\",\n      \"pmids\": [\"19073177\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ligand binding not yet demonstrated in this study\", \"In vivo skeletal relevance not addressed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Testing developmental function in vivo: reciprocal gain/loss-of-function in chick established that GREM2 controls epibranchial placode neurogenesis through regulation of Bmp4.\",\n      \"evidence\": \"In ovo gain- and loss-of-function in chick embryos with in situ hybridization\",\n      \"pmids\": [\"19836367\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of Bmp4 feedback regulation not defined\", \"No mammalian validation\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defining the biochemical mechanism and cardiac role: recombinant GREM2 was shown to bind BMP2/4/7 directly and inhibit BMP activity, and an AF-associated Q76E gain-of-function variant linked GREM2-controlled BMP signaling to atrial cardiomyocyte differentiation and cardiac laterality.\",\n      \"evidence\": \"Recombinant protein binding and luciferase assays, circular dichroism; AF proband sequencing, zebrafish overexpression with live imaging, mouse ES cell differentiation\",\n      \"pmids\": [\"22381466\", \"23223679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor-level mechanism not resolved\", \"Causal contribution of Q76E to human AF not established at population scale\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Confirming a required developmental role: Grem2 knockout mice display malformed incisors, showing GREM2 is necessary for normal tooth morphogenesis.\",\n      \"evidence\": \"Grem2-/- mouse model with histology and DEXA phenotyping\",\n      \"pmids\": [\"24686385\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular pathway driving dental phenotype not dissected\", \"Single-method phenotypic description\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Extending BMP fine-tuning to reproduction and cardiac differentiation: GREM2 was shown to antagonize BMP2/4 gene-specifically in human fetal ovarian somatic cells and to drive atrial-like cardiomyocyte differentiation from ES-derived embryoid bodies.\",\n      \"evidence\": \"Recombinant GREM2 on primary human fetal ovarian cells with qRT-PCR; mouse ES embryoid-body differentiation with molecular/histological/electrophysiological readouts\",\n      \"pmids\": [\"27385727\", \"27023256\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Gene-specificity mechanism of BMP modulation unexplained\", \"In vivo ovarian role not tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Resolving a non-BMP biochemical property: GREM2 carries a lysine-rich heparin/HS-binding motif dispensable for BMP antagonism, and the GREM2–BMP2 complex binds heparin more avidly than either partner alone.\",\n      \"evidence\": \"Site-directed mutagenesis, heparin-binding and cell-surface binding assays, BMP antagonism assay\",\n      \"pmids\": [\"28104757\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological role of heparin/HS binding in vivo unknown\", \"How HS binding shapes extracellular GREM2 distribution unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Uncovering a pathological SMAD-balance mechanism and a cancer role: GREM2 was shown to promote podocyte apoptosis by shifting SMAD2/3 up and SMAD1/5/8 down, and separately to maintain gastric cancer stem-cell properties through JNK signaling.\",\n      \"evidence\": \"Podocyte overexpression/knockdown with pSMAD Western blots and pharmacological rescue (SIS3, BMP-7); gastric CSC siRNA knockdown with JNK modulation and xenografts\",\n      \"pmids\": [\"30831151\", \"31345097\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How GREM2 differentially biases the two SMAD arms is unknown\", \"Link between BMP antagonism and JNK activation not mechanistically connected\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Linking human variants to mechanism: tooth-agenesis-associated GREM2 mutations reduce GREM2 transcriptional activity and lower MSX1 expression while altering cell migration/proliferation.\",\n      \"evidence\": \"Mutant/reference GREM2 transfection in SHED cells, luciferase, Western blot, migration/proliferation assays, qRT-PCR of MSX1/PAX9/AXIN2\",\n      \"pmids\": [\"33369218\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal chain from reduced GREM2 to dental agenesis not established in vivo\", \"Single cell-model functional inference\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defining receptor-level mechanism in metabolism and a compensatory disease role: GREM2 inhibits visceral fat browning by antagonizing BMP4/7–SMAD1/5/8 specifically via BMPR2, and decreased PRDC in pulmonary arterial hypertension acts compensatorily on smooth-muscle behavior.\",\n      \"evidence\": \"Grem2 overexpression/KO and Pdgfrα-specific Bmpr2 KO mice, recombinant Grem2, SMAD1/5/8 assays, ELISA; monocrotaline rat PAH model with PRDC supplementation and in vitro SMC assays\",\n      \"pmids\": [\"35349825\", \"35414785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether BMPR2 dependence generalizes to other GREM2 contexts unknown\", \"Source and regulation of circulating GREM2 not defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Confirming the skeletal phenotype genetically: partial and full Grem2 inactivation increased trabecular bone mass and enhanced BMP-2-stimulated osteoblast differentiation, validating GREM2 as an in vivo suppressor of osteoblastogenesis.\",\n      \"evidence\": \"Grem2+/- and Grem2-/- mice, micro-CT/DEXA, primary osteoblast differentiation with BMP-2 and qRT-PCR\",\n      \"pmids\": [\"38839844\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Sex-specificity of the BMD phenotype not explained\", \"Cell-type origin of the effect not isolated\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identifying an upstream transcriptional regulator and an inflammatory/fibrotic context: GREM2 is a STAT3 transcriptional target whose suppression reduces proinflammatory cytokines, and GREM2 knockdown prevents high-glucose/cholesterol-induced renal tubular fibrosis and senescence.\",\n      \"evidence\": \"STAT3 dual-luciferase and siRNA in LPS-stimulated thyroid cells; Grem2 siRNA in renal tubular epithelial cells with EMT markers and db/db mouse data\",\n      \"pmids\": [\"41322616\", \"39757007\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether STAT3-driven GREM2 acts through BMP antagonism in inflammation is unclear\", \"Direct vs indirect role of GREM2 in EMT not separated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How GREM2 mechanistically biases between the BMP (SMAD1/5/8) and TGF-β (SMAD2/3) arms, and how receptor selectivity (e.g., BMPR2 dependence) and heparan-sulfate binding shape its tissue-specific outputs, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of GREM2–BMP–receptor assembly\", \"Mechanism of SMAD-arm switching unknown\", \"Physiological function of HS binding undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 4, 13, 15]},\n      {\"term_id\": \"GO:0008201\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 2, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 4, 10, 13]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 5, 6]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"BMP2\", \"BMP4\", \"BMP7\", \"BMPR2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}